Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-07-02 17:17:53 ET · period of report 2026-07-01 · accession 0001061983-26-000072 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $48.51 | +1,112 | 64.3K | +2% | +$53.9K |
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | Lee Sung | EVP, CFO | S - Sale+OE | $87.79 | -1,112 | 63.2K | -2% | -$97.6K |
| DT | 2026-07-02 17:17 | 2026-07-01 | CYTK | Lee Sung | EVP, CFO | M - OptEx | $0.00 | -1,112 | 26.7K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-01 | M | A | 1,112 | $48.51 | 64,333 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-01 | S | D | 1,112 | $87.79 | 63,221 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2026-07-01 | M | D | 1,112 | $0.00 | 26,709 | D | $48.51 · 2025-06-02 to 2034-05-30 | 1,112 Common Stock |